Last 12 months
Inside the activity.
8 purchase rows · 122 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 8 |
| Apr 2026 | 0 | 44 |
| May 2026 | 2 | 16 |
| Jun 2026 | 2 | 24 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 1 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2024 Filed Mar 13, 2024 01:56 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 435 | $27.38 | $11,910.30 |
DisclosureSEC source: 0000950170-24-030479 · ownership.xml · nonDerivative · entry 5 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 554,385 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.27 to $27.49, inclusive. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:56 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 160,670 | $26.72 | $4,293,102.40 |
DisclosureSEC source: 0000950170-24-030479 · ownership.xml · nonDerivative · entry 4 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 554,820 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.20 to $27.18, inclusive. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:56 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 202,238 | $25.30 | $5,116,621.40 |
DisclosureSEC source: 0000950170-24-030479 · ownership.xml · nonDerivative · entry 3 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 715,490 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.20 to $26.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:56 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionCommon Stock | 209,412 | $5.54 | $1,160,142.48 |
DisclosureSEC source: 0000950170-24-030479 · ownership.xml · nonDerivative · entry 2 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 917,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:56 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionCommon Stock | 153,931 | $5.54 | $852,777.74 |
DisclosureSEC source: 0000950170-24-030479 · ownership.xml · nonDerivative · entry 1 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
HIGH SUSANNA GATTIChief Operating Officer
|
SaleCommon Stock | 291 | $27.41 | $7,976.31 |
DisclosureSEC source: 0000950170-24-030485 · ownership.xml · nonDerivative · entry 2 HIGH SUSANNA GATTI · CIK 0001691005 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,092 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.39 to $27.42, inclusive. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
HIGH SUSANNA GATTIChief Operating Officer
|
SaleCommon Stock | 26,908 | $26.66 | $717,367.28 |
DisclosureSEC source: 0000950170-24-030485 · ownership.xml · nonDerivative · entry 1 HIGH SUSANNA GATTI · CIK 0001691005 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.32 to $27.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 3,841 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · derivative · entry 10 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 3,841 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option was granted on July 31, 2020, with 100% of the option to vest upon the clearance date of an IND application submitted to the FDA by the Company with respect to one ofitsproduct candidates. On July 5, 2022, in connection with the clearance by the FDA of the Company's IND application for DYNE-251, the Compensation Committee determined thattheperformance condition had been achieved. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 86,159 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · derivative · entry 9 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,309 Underlying: Common Stock · 86,159 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments beginning on October 31, 2020. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 689 | $27.31 | $18,816.59 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · nonDerivative · entry 5 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,184 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.27 to $27.39, inclusive. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 54,648 | $26.72 | $1,460,194.56 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · nonDerivative · entry 4 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,873 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.25 to $27.19, inclusive. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 34,663 | $25.46 | $882,519.98 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · nonDerivative · entry 3 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,521 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.25 to $26.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionCommon Stock | 3,841 | $5.54 | $21,279.14 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · nonDerivative · entry 2 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.25 to $26.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 10:04 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionCommon Stock | 86,159 | $5.54 | $477,320.86 |
DisclosureSEC source: 0000950170-24-030484 · ownership.xml · nonDerivative · entry 1 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:56 UTC |
Beskrovnaya OxanaChief Scientific Officer
|
SaleCommon Stock | 2,373 | $25.85 | $61,342.05 |
DisclosureSEC source: 0000950170-24-029615 · ownership.xml · nonDerivative · entry 1 Beskrovnaya Oxana · CIK 0001824542 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,433 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.84 to $26.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Includes 140,948 unvested RSUs. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:57 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 9,086 | $25.85 | $234,873.10 |
DisclosureSEC source: 0000950170-24-029616 · ownership.xml · nonDerivative · entry 1 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 554,385 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.84 to $26.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:56 UTC |
HIGH SUSANNA GATTIChief Operating Officer
|
SaleCommon Stock | 1,591 | $25.85 | $41,127.35 |
DisclosureSEC source: 0000950170-24-029614 · ownership.xml · nonDerivative · entry 1 HIGH SUSANNA GATTI · CIK 0001691005 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,291 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.84 to $26.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Includes 151,099 unvested RSUs. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:52 UTC |
Farwell WildonChief Medical Officer
|
SaleCommon Stock | 1,557 | $26.20 | $40,793.40 |
DisclosureSEC source: 0000950170-24-029609 · ownership.xml · nonDerivative · entry 2 Farwell Wildon · CIK 0001847941 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,175 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 14, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.20 to $26.23, inclusive. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:52 UTC |
Farwell WildonChief Medical Officer
|
SaleCommon Stock | 8,364 | $25.80 | $215,791.20 |
DisclosureSEC source: 0000950170-24-029609 · ownership.xml · nonDerivative · entry 1 Farwell Wildon · CIK 0001847941 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,732 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on March 2, 2021 and November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.51 to $26.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Included 128,010 unvested RSUs. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:50 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 2,434 | $25.85 | $62,918.90 |
DisclosureSEC source: 0000950170-24-029607 · ownership.xml · nonDerivative · entry 1 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,184 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.84 to $26.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| March 07, 2024 Filed Mar 12, 2024 01:45 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 2,273 | $25.85 | $58,757.05 |
DisclosureSEC source: 0000950170-24-029603 · ownership.xml · nonDerivative · entry 1 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,955 F1 · shares: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.84 to $26.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. F3 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionStock option (right to buy) · Derivative | 36,637 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · derivative · entry 9 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 342,681 Underlying: Common Stock · 36,637 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionStock option (right to buy) · Derivative | 57,843 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · derivative · entry 8 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 57,843 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 1,414 | $29.70 | $41,995.80 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 6 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 563,471 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $29.58 to $29.88, inclusive. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 74,090 | $29.23 | $2,165,650.70 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 5 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 564,885 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.56 to $29.56, inclusive. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 18,976 | $28.25 | $536,072.00 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 4 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 638,975 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $28.48, inclusive. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionCommon Stock | 94,480 | $5.54 | $523,419.20 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 3 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 657,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 24,260 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · derivative · entry 8 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,260 shares Expires 2029-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on February 26, 2019. The shares underlying the option vest over four years, with 25% of the shares vesting on February 1, 2020 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 1,442 | $29.70 | $42,827.40 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 6 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,618 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $29.58 to $29.88, inclusive. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 8,715 | $29.06 | $253,257.90 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 5 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,060 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.56 to $29.51, inclusive. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 14,103 | $28.25 | $398,409.75 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 4 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,775 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $28.48, inclusive. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionCommon Stock | 24,260 | $0.73 | $17,709.80 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 3 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionStock option (right to buy) · Derivative | 9,311 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · derivative · entry 7 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,311 shares Expires 2030-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on January 6, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on December 2, 2020 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 564 | $28.65 | $16,158.60 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · nonDerivative · entry 5 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,228 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 11, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.55 to $28.83, inclusive. F1 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 8,747 | $28.22 | $246,840.34 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · nonDerivative · entry 4 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,792 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 11, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $28.48, inclusive. F1 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 9,311 | $1.03 | $9,590.33 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · nonDerivative · entry 3 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:07 UTC | SaleCommon Stock | 17,099 | $30.05 | $513,824.95 |
DisclosureSEC source: 0001415889-24-006764 · form4-03052024_100352.xml · nonDerivative · entry 2 Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Atlas Venture Opportunity Fund II, L.P. · CIK 0001885327 · 10% owner Atlas Venture Associates Opportunity II, LP · CIK 0001935814 · 10% owner Atlas Venture Associates Opportunity II, LLC · CIK 0001935810 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 847,388 F4 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund II, L.P. on January 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. Each of AVAO II LP and AVAO II LLC disclaims Section 16 beneficial ownership of the securities held by AVOF II, except to the extent of its pecuniary interest therein, if any. Read SEC document |
|
| March 01, 2024 Filed Mar 5, 2024 17:07 UTC | SaleCommon Stock | 29,435 | $30.05 | $884,521.75 |
DisclosureSEC source: 0001415889-24-006764 · form4-03052024_100352.xml · nonDerivative · entry 1 Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Atlas Venture Opportunity Fund II, L.P. · CIK 0001885327 · 10% owner Atlas Venture Associates Opportunity II, LP · CIK 0001935814 · 10% owner Atlas Venture Associates Opportunity II, LLC · CIK 0001935810 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,458,691 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund I, L.P. on January 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). The general partner of AVOF I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by AVOF I, except to the extent of its pecuniary interest therein, if any. Read SEC document |
|
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 17,099 | $30.05 | $513,824.95 |
DisclosureSEC source: 0001415889-24-006766 · form4-03052024_100311.xml · nonDerivative · entry 2 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 847,388 F4 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund II, L.P. on January 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, LP ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. The Reporting Person is a member of AVAO II LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF II, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 29,435 | $30.05 | $884,521.75 |
DisclosureSEC source: 0001415889-24-006766 · form4-03052024_100311.xml · nonDerivative · entry 1 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,458,691 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund I, L.P. on January 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). The general partner of AVOF I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The reporting person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by AVOF I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionStock option (right to buy) · Derivative | 5,520 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · derivative · entry 7 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,343 Underlying: Common Stock · 5,520 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
SaleCommon Stock | 5,520 | $27.50 | $151,800.00 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 2 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 563,471 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $27.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:38 UTC |
Brumm Joshua TDirector · CEO & President
|
Exercise / conversionCommon Stock | 5,520 | $5.54 | $30,580.80 |
DisclosureSEC source: 0000950170-24-024300 · ownership.xml · nonDerivative · entry 1 Brumm Joshua T · CIK 0001528826 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 568,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 530,300 unvested RSUs. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 4,268 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · derivative · entry 7 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,260 Underlying: Common Stock · 4,268 shares Expires 2029-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on February 26, 2019. The shares underlying the option vest over four years, with 25% of the shares vesting on February 1, 2020 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
SaleCommon Stock | 4,268 | $27.50 | $117,370.00 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 2 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,618 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $27.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
McNeill JonathanChief Business Officer
|
Exercise / conversionCommon Stock | 4,268 | $0.73 | $3,115.64 |
DisclosureSEC source: 0000950170-24-024299 · ownership.xml · nonDerivative · entry 1 McNeill Jonathan · CIK 0001824673 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 137,058 unvested RSUs. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionStock option (right to buy) · Derivative | 3,429 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · derivative · entry 6 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,311 Underlying: Common Stock · 3,429 shares Expires 2030-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on January 6, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on December 2, 2020 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
SaleCommon Stock | 3,429 | $27.50 | $94,297.50 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · nonDerivative · entry 2 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,228 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 11, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $27.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. F1 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 02:37 UTC |
Scalzo Richard WilliamSVP, Head of Finance & Admin.
|
Exercise / conversionCommon Stock | 3,429 | $1.03 | $3,531.87 |
DisclosureSEC source: 0000950170-24-024298 · ownership.xml · nonDerivative · entry 1 Scalzo Richard William · CIK 0001789545 · SVP, Head of Finance & Admin. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 118,605 unvested RSUs. Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 19:13 UTC |
Atlas Venture Fund XI, L.P.10% owner
Atlas Venture Associates XI, L.P.10% owner
Atlas Venture Associates XI, LLC10% owner
|
SaleCommon Stock | 210 | $25.25 | $5,302.50 |
DisclosureSEC source: 0001415889-24-005777 · form4-02292024_120212.xml · nonDerivative · entry 18 Atlas Venture Fund XI, L.P. · CIK 0001708269 · 10% owner Atlas Venture Associates XI, L.P. · CIK 0001780068 · 10% owner Atlas Venture Associates XI, LLC · CIK 0001780067 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Atlas Venture Opportunity Fund II, L.P. · CIK 0001885327 · 10% owner Atlas Venture Associates Opportunity II, LP · CIK 0001935814 · 10% owner Atlas Venture Associates Opportunity II, LLC · CIK 0001935810 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 864,487 F7 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund II, L.P. on January 10, 2024. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.25 to $25.255 inclusive. F8 · ownership.nature: The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. Each of AVAO II LP and AVAO II LLC disclaims Section 16 beneficial ownership of the securities held by AVOF II, except to the extent of its pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.